Relationships between plasma lipoprotein concentrations and insulin action in an obese hyperinsulinemic population. 1987

W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard

Relationships have been observed between lipoprotein concentrations and insulin action. These relationships may be important in explaining the association of insulin resistance and abnormalities of lipoprotein metabolism found in obesity, diabetes, and hypertriglyceridemia. We have measured plasma lipoprotein concentrations and indices of insulin action in 85 men and 56 women, all of whom were normolipidemic and had normal glucose tolerance. The subjects were obese Southwestern American Indians (body mass index 34 +/- 1). Insulin action was measured via the hyperinsulinemic clamp with simultaneous indirect calorimetry. Triglyceride concentrations were inversely related to rates of total insulin-mediated glucose disposal (in men and women, respectively, r = -.37, P less than .01; r = -.24, P less than .10), glucose storage (r = -.31, P less than .01; r = -.25, P less than .10), increase in glucose oxidation (r = -.29, P less than .01; r = -.24, P less than .10), and, in men only, suppression of endogenous glucose production (r = -.32, P less than .01). High-density lipoprotein (HDL) cholesterol concentration was positively related to rates of total insulin-mediated glucose disposal (r = .35, P less than .01; r = .33, P less than .05), increase in carbohydrate oxidation (r = .40, P less than .001; r = .39, P less than .001), suppression of endogenous glucose production (r = .24, P less than .05; r = .29, P less than .05), and, in men only, glucose storage (r = .35, P less than .001).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008074 Lipoproteins Lipid-protein complexes involved in the transportation and metabolism of lipids in the body. They are spherical particles consisting of a hydrophobic core of TRIGLYCERIDES and CHOLESTEROL ESTERS surrounded by a layer of hydrophilic free CHOLESTEROL; PHOSPHOLIPIDS; and APOLIPOPROTEINS. Lipoproteins are classified by their varying buoyant density and sizes. Circulating Lipoproteins,Lipoprotein,Lipoproteins, Circulating
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005260 Female Females
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
September 1983, American journal of epidemiology,
W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
September 1988, International journal of clinical pharmacology, therapy, and toxicology,
W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
July 1994, The American journal of clinical nutrition,
W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
November 1997, Diabetes care,
W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
January 1993, Annals of nutrition & metabolism,
W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
November 1990, The Veterinary record,
W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
January 1999, Journal of medicinal food,
W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
June 1985, Journal of endocrinological investigation,
W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
November 2011, Translational research : the journal of laboratory and clinical medicine,
W G Abbott, and S Lillioja, and A A Young, and J K Zawadzki, and H Yki-Järvinen, and L Christin, and B V Howard
July 1991, Clinical chemistry,
Copied contents to your clipboard!